Building a digitized and customer-oriented hospital customer service system is conducive to better service at the hospital.Such a system is an open customer service and management system,comprising digitized customer relation management and service platform,digital intelligent IVR customer service system,video interaction service system for hospital wards,IOT-based health management and service system,and 3G-based seamless pre-hospital and post-hospital green emergency rescue system,as well as other customer service systems including the outpatient auto-calling,self-service,information release,payment management,and IOT-based customer management system.By means of thorough customer analysis,automatic service trigger-off mechanism and considerate customer service,digitized hospital customer service system realized value of the hospital while providing the customers with valuable services.

The widespread application of adjuvant therapy has shown clear benefits in the treatment of operable breast cancer. It is essential for the clinicians to select appropriate adjuvant regimens for this heterogeneous group of patients. Recent data from clinical trials evaluating the utility of adjuvant therapy were reviewed.

Objectives To investigate the relations between serum E2,T level and vascular dementia (VD) and therapy effect of Chinese medicine.Methods Seventy patients were selected and randomly divided into two groups:experimental group,which was treated with Chinese medicine and control group with western medicine.Results There was marked difference in E2 of female patient and E2,E2/T and T of male patient between experimental group and control group (P

FDP/FIP (88.8%), respectively; (3) The diagnostic positivity of combination assay was 80.0% in low or negative AFP producing HCC, while 95.7% in those with elevated AFP. Our data suggested that the combination assay of serum tumor enzyme markers was valuable in the diagnosis of HCC, especially in low or negative AFP HCC patients

Antineoplastic Agents ; therapeutic use ; Benzamides ; Chemotherapy, Adjuvant ; Gastrointestinal Neoplasms ; drug therapy ; metabolism ; pathology ; surgery ; Gastrointestinal Stromal Tumors ; drug therapy ; metabolism ; pathology ; surgery ; Humans ; Imatinib Mesylate ; Indoles ; therapeutic use ; Mutation ; Neoplasm Staging ; Piperazines ; therapeutic use ; Proto-Oncogene Proteins c-kit ; metabolism ; Pyrimidines ; therapeutic use ; Pyrroles ; therapeutic use ; Receptor, Epidermal Growth Factor ; genetics ; metabolism ; Vascular Endothelial Growth Factor A ; metabolism

Percutaneous transluminal coronary angioplasty (PTCA) has become one of the most important treatment method in coronary artery disease along with coronary bypass operation and medicine in recent years.Restenosis after intervention becomes the Achili's heel in our daily treatment.In some degree stenting can reduce restenosis,but the restenosis after stenting is still over 20%.The focus of the treatment of restenosis over the last 2 decades has been through the application of pharmacologically active agents and mechanical approaches using a host of different devices.But this frequent and costly complication of percutaneous revascularization techniques has proved refractory to all such therapies.This review will focus on the studies that have been done during recent years,it will cover the mechanism of restenosis after PTCA and stenting,the risk factors involved in the restenosis,and the prevention and treatment of restenosis.